UP!

ACLS $74.45

ACLS target price
74.45
0
0
Axcelis Technologies, Inc.
Type
Public
Traded as
  • NASDAQ: ACLS
  • S&P 600 component
Industry Semiconductor equipment
Founded Incorporated 1995
Headquarters Beverly, Massachusetts, United States
Key people
Mary G. Puma, Chairman and CEO
Revenue Decrease $266.9 million USD (2016)
Operating income
Decrease $16.6 million USD (2016)
Net income
Decrease $11.0 million USD (2016)
Number of employees
Decrease 845 (2016)
Website axcelis.com

Axcelis Technologies, Inc. is an American company engaging in the design, manufacture, and servicing of capital equipment for the semiconductor manufacturing industry worldwide. It produces ion implantation systems, including high and medium current implanters, and high energy implanters, and curing systems used in the fabrication of semiconductor chips. The company was incorporated in 1995 and is headquartered in Beverly, Massachusetts, United States.

In 2000, Eaton Corporation spun off its semiconductor manufacturing equipment business as Axcelis Technologies.

On December 4, 2012 Axcelis Technologies decided "...that it will exit the dry-strip business and divest its dry-strip intellectual property and technology, including the advanced non-oxidizing process technology of its Integra product line, to Lam Research,...Axcelis will continue to ship its 300 mm dry-strip products through August 2013..."

Coordinates: 42°34′33″N 70°54′18″W / 42.57583°N 70.90500°W / 42.57583; -70.90500

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-11-01 Future report Set alerts
Q2 2022 2022-08-03 1.32 1.32
Q1 2022 2022-05-04 1.22 1.22
Q4 2021 2022-02-07 1.05 1.05
Q3 2021 2021-11-03 0.82 0.82
Q2 2021 2021-08-04 0.55 0.55
Q1 2021 2021-05-04 0.48 0.48
Q4 2020 2021-02-10 0.32 0.32
Q3 2020 2020-11-05 0.32 0.32
Q2 2020 2020-08-04 0.39 0.39

Ratings

2016-07-10 Reiterated Rating B. Riley Buy
2016-07-05 Reiterated Rating B. Riley Buy
2016-06-20 Reiterated Rating B. Riley Buy $4.00
2016-06-15 Reiterated Rating B. Riley Buy $4.00
2016-05-08 Reiterated Rating B. Riley Buy $4.25
2016-05-03 Reiterated Rating B. Riley Buy $4.25
2016-04-25 Reiterated Rating B. Riley Buy $4.50
2016-04-19 Reiterated Rating B. Riley Buy $4.50
2016-04-13 Reiterated Rating B. Riley Buy $4.50
2016-04-08 Reiterated Rating B. Riley Buy $4.50
2016-03-13 Reiterated Rating B. Riley Buy $4.50
2016-03-08 Reiterated Rating B. Riley Buy $4.50
2016-02-28 Reiterated Rating B. Riley Buy $4.50
2016-02-23 Reiterated Rating B. Riley Buy $4.50
2016-02-08 Reiterated Rating B. Riley Buy $4.50
2016-02-03 Reiterated Rating B. Riley Buy $4.50
2016-01-17 Reiterated Rating B. Riley Buy $4.50
2016-01-12 Reiterated Rating B. Riley Buy $4.50
2016-01-05 Reiterated Rating Needham & Company LLC Buy $4.50
2015-11-10 Reiterated Rating B. Riley Buy $4.50
2015-11-05 Lower Price Target Benchmark Co. Buy $4.50 to $4.00
2015-11-05 Reiterated Rating B. Riley Buy $5.00 to $4.50
2015-10-01 Reiterated Rating B. Riley Buy $5.00
2015-08-10 Reiterated Rating B. Riley Buy $5.00
2015-08-05 Reiterated Rating B. Riley Buy $5.00
2015-07-01 Initiated Coverage Benchmark Co. Buy $4.50
2015-06-29 Reiterated Rating B. Riley Buy $4.25
2015-06-24 Reiterated Rating B. Riley Buy $4.25
2015-05-26 Reiterated Rating B. Riley Buy $4.25
2015-05-18 Reiterated Rating Stifel Nicolaus Buy $3.00 to $4.00
2015-05-09 Reiterated Rating Craig Hallum Buy $5.00
2015-05-09 Reiterated Rating Needham & Company LLC Buy $4.00 to $4.50
2015-05-06 Reiterated Rating B. Riley Buy $3.50 to $4.25
2015-04-02 Reiterated Rating B. Riley Buy $3.50
2015-02-06 Reiterated Rating B. Riley Buy $3.50
2014-08-27 Initiated Stifel Buy $3
2014-08-26 Initiated Coverage Stifel Nicolaus Buy $3.00
2014-01-09 Initiated Needham Buy $3.50
2014-01-09 Initiated Coverage Needham & Company LLC Buy $3.50
2013-12-12 Initiated Coverage B. Riley Buy $3.00
2008-09-17 Upgrade Citigroup Hold to Buy
2008-05-02 Reiterated Broadpoint Capital Underperform $3.50 to $5
2008-04-15 Reiterated Deutsche Securities Hold $5 to $4.50
2008-02-01 Reiterated Deutsche Securities Hold $6 to $5
2008-01-29 Initiated Broadpoint Capital Underperform $3.50
2007-08-02 Reiterated Lehman Brothers Underweight $6 to $5
2007-05-03 Downgrade Needham & Co Buy to Hold
2007-05-03 Downgrade AG Edwards Hold to Sell
2007-04-09 Downgrade Lehman Brothers Equal-weight to Underweight
2007-02-01 Reiterated Goldman Sachs Buy $7 to $8
2016-07-10 Reiterated Rating B. Riley Buy
2016-07-05 Reiterated Rating B. Riley Buy
2016-06-20 Reiterated Rating B. Riley Buy $4.00
2016-06-15 Reiterated Rating B. Riley Buy $4.00
2016-05-08 Reiterated Rating B. Riley Buy $4.25

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
HARDIS STEPHEN R 0.63%  (702068) ACLS / LXK / PGR /
PUMA MARY G Chairman, President and CEO 0.20%  (226048) ACLS / NDSN /
ZAGER JAY CFO and EVP 0.16%  (178035) ACLS /
THOMPSON H BRIAN 0.09%  (104185) ACLS / PAG / PCO / SONS /
JENNINGS WILLIAM C 0.08%  (92185) ACLS / SLGN / SPNC /
BREWER KEVIN J EVP, Operations 0.05%  (54223) ACLS /
FALLON LYNNETTE C Executive VP, HR/Legal 0.05%  (52517) ACLS /
FLYNN MATTHEW P EVP, Customer Operations 0.04%  (45527) ACLS /
Bintz William J EVP, Prod. Dev., Eng. & Mktg 0.04%  (43500) ACLS /
FLETCHER R JOHN 0.04%  (40235) ACLS / MRNA / SPNC /
ALDEBORGH JOHN E EVP, Customer Operations 0.03%  (37872) ACLS /
George Arthur L Jr 0.03%  (36689) ACLS / NDSN /
Lawson Douglas A. EVP, Corporate Mktg & Strategy 0.03%  (36324) ACLS /
NETTLES PATRICK H 0.03%  (31360) ACLS / CIEN / PGR /
FAUBERT RICHARD J 0.02%  (26689) ACLS / ESIO /
St Dennis Thomas 0.02%  (26689) ACLS / FORM / MTSN / VECO /
KURTZWEIL JOHN T 0.02%  (26498) ACLS / CREE / EXTR / MERU /
Low Russell EVP, Engineering 0.02%  (21799) ACLS /
KEITHLEY JOSEPH P 0.02%  (21439) ACLS / MTRN / NDSN /
Lundberg Barbara J 0.01%  (10262) ACLS /
BRAUN EDWARD H 0.01%  (10000) ACLS / VECO /